Related Experiment Video
Updated: May 20, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Ischemic nephropathy - pathogenesis and treatment
Marcin Adamczak1, Andrzej Wiecek
1Department of Nephrology, Endocrinology and Metabolic Diseases. Medical University of Silesia, Katowice, Poland.
Abstract:
In this review paper we would like to summarized the current knowledge concerning the pathogenesis and treatment of ischemic nephropathy. Epidemiological data suggest that the prevalence of ischemic nephropathy increases, especially among older individuals. The pathogenesis of this disease is more complex than just narrowing of the renal artery due to atherosclerosis. Renin-angiotension system, growth factors, different cytokines and chemokines may participate in the pathogenesis of ischemic nephropathy. Precise, clinically useful diagnostic criteria of the ischemic nephropathy have not been established, yet. Concerted medical management remains now the main therapeutic option for majority of patients with this disease and only in the selected patients revascularisation is nowadays indicated.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy
Ischemic Stroke ll: Pathophysiology
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management

